Photo taken from: Paolo Tarantino / Twitter
Aug 23, 2023, 23:49
Paolo Tarantino: Interesting pan-cancer evaluation of HER2-low expression out on Annals of Oncology.
Paolo Tarantino, a Research Fellow at the Dana-Farber Cancer Institute, shared the following insights on Twitter:
“Interesting pan-cancer evaluation of HER2-low expression out on Annals of Oncology (n=4701). Half of all tumors expressed HER2, with notable differences across histologies. Among patients with >1 metastatic biopsy, there was wide discordance across lesions.”
For full text click here
Source: Paolo Tarantino / Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14